nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimetindene—Cyclobenzaprine—Tamoxifen—pancreatic cancer	0.143	0.15	CrCrCtD
Dimetindene—Doxylamine—Tamoxifen—pancreatic cancer	0.132	0.138	CrCrCtD
Dimetindene—Tripelennamine—Tamoxifen—pancreatic cancer	0.119	0.125	CrCrCtD
Dimetindene—Bromodiphenhydramine—Tamoxifen—pancreatic cancer	0.111	0.116	CrCrCtD
Dimetindene—Dimetacrine—Tamoxifen—pancreatic cancer	0.111	0.116	CrCrCtD
Dimetindene—Clofedanol—Tamoxifen—pancreatic cancer	0.0904	0.0946	CrCrCtD
Dimetindene—Orphenadrine—Tamoxifen—pancreatic cancer	0.0875	0.0916	CrCrCtD
Dimetindene—Promazine—Tamoxifen—pancreatic cancer	0.0835	0.0874	CrCrCtD
Dimetindene—Diphenhydramine—Tamoxifen—pancreatic cancer	0.0777	0.0813	CrCrCtD
Dimetindene—KCNH2—Sunitinib—pancreatic cancer	0.0176	1	CbGbCtD
Dimetindene—HRH1—GPCR ligand binding—CNR1—pancreatic cancer	5.39e-05	0.00202	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—SSTR1—pancreatic cancer	5.38e-05	0.00202	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PPY—pancreatic cancer	5.37e-05	0.00201	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CNR1—pancreatic cancer	5.31e-05	0.00199	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PPY—pancreatic cancer	5.28e-05	0.00198	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—SSTR2—pancreatic cancer	5.27e-05	0.00198	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—GCG—pancreatic cancer	5.21e-05	0.00195	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—SSTR2—pancreatic cancer	5.18e-05	0.00194	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	5.13e-05	0.00193	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—GCG—pancreatic cancer	5.12e-05	0.00192	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CCKBR—pancreatic cancer	5.09e-05	0.00191	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CCKBR—pancreatic cancer	5.01e-05	0.00188	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—AGTR1—pancreatic cancer	4.97e-05	0.00186	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	4.91e-05	0.00184	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—AGTR1—pancreatic cancer	4.89e-05	0.00183	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—GAST—pancreatic cancer	4.82e-05	0.00181	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—GAST—pancreatic cancer	4.74e-05	0.00178	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	4.74e-05	0.00178	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—SCT—pancreatic cancer	4.57e-05	0.00171	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—SCT—pancreatic cancer	4.49e-05	0.00169	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—GAST—pancreatic cancer	4.37e-05	0.00164	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CCK—pancreatic cancer	4.36e-05	0.00163	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—GAST—pancreatic cancer	4.3e-05	0.00162	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CCK—pancreatic cancer	4.29e-05	0.00161	CbGpPWpGaD
Dimetindene—CHRM2—Regulation of Actin Cytoskeleton—NRAS—pancreatic cancer	4.27e-05	0.0016	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CNR2—pancreatic cancer	4.25e-05	0.00159	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—GLP1R—pancreatic cancer	4.25e-05	0.00159	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CNR2—pancreatic cancer	4.18e-05	0.00157	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—GLP1R—pancreatic cancer	4.18e-05	0.00157	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CCKAR—pancreatic cancer	4.18e-05	0.00157	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	4.17e-05	0.00156	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—SCT—pancreatic cancer	4.15e-05	0.00156	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CCKAR—pancreatic cancer	4.11e-05	0.00154	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—SCT—pancreatic cancer	4.08e-05	0.00153	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PRLHR—pancreatic cancer	3.97e-05	0.00149	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CCK—pancreatic cancer	3.96e-05	0.00148	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PRLHR—pancreatic cancer	3.9e-05	0.00146	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CCK—pancreatic cancer	3.89e-05	0.00146	CbGpPWpGaD
Dimetindene—CHRM2—Regulation of Actin Cytoskeleton—EGFR—pancreatic cancer	3.89e-05	0.00146	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CNR2—pancreatic cancer	3.86e-05	0.00145	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—GLP1R—pancreatic cancer	3.86e-05	0.00145	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CNR2—pancreatic cancer	3.79e-05	0.00142	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—GLP1R—pancreatic cancer	3.79e-05	0.00142	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CCKAR—pancreatic cancer	3.79e-05	0.00142	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—IAPP—pancreatic cancer	3.76e-05	0.00141	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CCKAR—pancreatic cancer	3.73e-05	0.0014	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ACVR1B—pancreatic cancer	3.73e-05	0.0014	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ZNRF3—pancreatic cancer	3.73e-05	0.0014	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—IAPP—pancreatic cancer	3.7e-05	0.00139	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—CXCL8—pancreatic cancer	3.7e-05	0.00139	CbGpPWpGaD
Dimetindene—CHRM2—Regulation of Actin Cytoskeleton—KRAS—pancreatic cancer	3.68e-05	0.00138	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ACVR1B—pancreatic cancer	3.67e-05	0.00138	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ZNRF3—pancreatic cancer	3.67e-05	0.00138	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PTHLH—pancreatic cancer	3.61e-05	0.00135	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—TNF—pancreatic cancer	3.57e-05	0.00134	CbGpPWpGaD
Dimetindene—KCNH2—Neuronal System—HRAS—pancreatic cancer	3.56e-05	0.00133	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PTHLH—pancreatic cancer	3.55e-05	0.00133	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—SHH—pancreatic cancer	3.46e-05	0.0013	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—IAPP—pancreatic cancer	3.42e-05	0.00128	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—SHH—pancreatic cancer	3.4e-05	0.00128	CbGpPWpGaD
Dimetindene—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	3.38e-05	0.00127	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—DTX1—pancreatic cancer	3.37e-05	0.00127	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SSTR3—pancreatic cancer	3.37e-05	0.00127	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—IAPP—pancreatic cancer	3.36e-05	0.00126	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SSTR3—pancreatic cancer	3.32e-05	0.00124	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—DTX1—pancreatic cancer	3.32e-05	0.00124	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—SST—pancreatic cancer	3.3e-05	0.00124	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PTHLH—pancreatic cancer	3.28e-05	0.00123	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PTCH1—pancreatic cancer	3.28e-05	0.00123	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—SST—pancreatic cancer	3.25e-05	0.00122	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	3.24e-05	0.00122	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SSTR1—pancreatic cancer	3.23e-05	0.00121	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PTHLH—pancreatic cancer	3.23e-05	0.00121	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PTCH1—pancreatic cancer	3.23e-05	0.00121	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SSTR1—pancreatic cancer	3.18e-05	0.00119	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PPY—pancreatic cancer	3.17e-05	0.00119	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PPY—pancreatic cancer	3.12e-05	0.00117	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SSTR2—pancreatic cancer	3.11e-05	0.00117	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SSTR2—pancreatic cancer	3.06e-05	0.00115	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CNR1—pancreatic cancer	3.05e-05	0.00114	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCKBR—pancreatic cancer	3.01e-05	0.00113	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—SST—pancreatic cancer	3e-05	0.00113	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CNR1—pancreatic cancer	3e-05	0.00113	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	2.99e-05	0.00112	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCKBR—pancreatic cancer	2.96e-05	0.00111	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	2.95e-05	0.00111	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—SST—pancreatic cancer	2.95e-05	0.00111	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—GCG—pancreatic cancer	2.94e-05	0.0011	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	2.94e-05	0.0011	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—GCG—pancreatic cancer	2.9e-05	0.00109	CbGpPWpGaD
Dimetindene—HRH1—G alpha (q) signalling events—PIK3CA—pancreatic cancer	2.86e-05	0.00107	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—DTX4—pancreatic cancer	2.83e-05	0.00106	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GLI1—pancreatic cancer	2.83e-05	0.00106	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—AGTR1—pancreatic cancer	2.81e-05	0.00105	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	2.79e-05	0.00105	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—DTX4—pancreatic cancer	2.78e-05	0.00104	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GLI1—pancreatic cancer	2.78e-05	0.00104	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CNR1—pancreatic cancer	2.77e-05	0.00104	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—AGTR1—pancreatic cancer	2.76e-05	0.00104	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NRP1—pancreatic cancer	2.75e-05	0.00103	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PPP2R5B—pancreatic cancer	2.75e-05	0.00103	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CNR1—pancreatic cancer	2.72e-05	0.00102	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PPP2R5B—pancreatic cancer	2.7e-05	0.00101	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NRP1—pancreatic cancer	2.7e-05	0.00101	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—GCG—pancreatic cancer	2.67e-05	0.001	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HEY2—pancreatic cancer	2.65e-05	0.000993	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—GCG—pancreatic cancer	2.63e-05	0.000987	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HEY2—pancreatic cancer	2.6e-05	0.000977	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GAST—pancreatic cancer	2.58e-05	0.00097	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	2.56e-05	0.000961	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—AGTR1—pancreatic cancer	2.55e-05	0.000957	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GAST—pancreatic cancer	2.54e-05	0.000954	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—AGTR1—pancreatic cancer	2.51e-05	0.000941	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SCT—pancreatic cancer	2.45e-05	0.000919	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HEY1—pancreatic cancer	2.45e-05	0.000919	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SCT—pancreatic cancer	2.41e-05	0.000905	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HEY1—pancreatic cancer	2.41e-05	0.000905	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	2.37e-05	0.000889	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCK—pancreatic cancer	2.34e-05	0.000877	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCK—pancreatic cancer	2.3e-05	0.000863	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CNR2—pancreatic cancer	2.28e-05	0.000855	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GLP1R—pancreatic cancer	2.28e-05	0.000855	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CXCL8—pancreatic cancer	2.28e-05	0.000854	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CNR2—pancreatic cancer	2.24e-05	0.000841	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GLP1R—pancreatic cancer	2.24e-05	0.000841	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCKAR—pancreatic cancer	2.24e-05	0.000841	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CXCL8—pancreatic cancer	2.24e-05	0.00084	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCKAR—pancreatic cancer	2.2e-05	0.000827	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—JAG2—pancreatic cancer	2.17e-05	0.000815	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MEN1—pancreatic cancer	2.14e-05	0.000804	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—JAG2—pancreatic cancer	2.14e-05	0.000802	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MEN1—pancreatic cancer	2.11e-05	0.000791	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SHH—pancreatic cancer	2.04e-05	0.000767	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NOTCH4—pancreatic cancer	2.03e-05	0.000762	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IAPP—pancreatic cancer	2.02e-05	0.000757	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SHH—pancreatic cancer	2.01e-05	0.000754	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NOTCH4—pancreatic cancer	2e-05	0.00075	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IAPP—pancreatic cancer	1.99e-05	0.000745	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PTHLH—pancreatic cancer	1.94e-05	0.000727	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PTCH1—pancreatic cancer	1.94e-05	0.000727	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PTCH1—pancreatic cancer	1.91e-05	0.000715	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PTHLH—pancreatic cancer	1.91e-05	0.000715	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SST—pancreatic cancer	1.77e-05	0.000665	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.75e-05	0.000656	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SST—pancreatic cancer	1.74e-05	0.000654	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—JAG1—pancreatic cancer	1.73e-05	0.00065	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NOTCH3—pancreatic cancer	1.73e-05	0.000648	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.72e-05	0.000645	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	1.71e-05	0.00064	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	1.7e-05	0.000637	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CNR1—pancreatic cancer	1.63e-05	0.000613	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	1.61e-05	0.000604	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PIK3CG—pancreatic cancer	1.59e-05	0.000595	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GCG—pancreatic cancer	1.58e-05	0.000592	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	1.56e-05	0.000586	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GCG—pancreatic cancer	1.55e-05	0.000583	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.54e-05	0.000576	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.51e-05	0.000567	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—AGTR1—pancreatic cancer	1.51e-05	0.000565	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—STK11—pancreatic cancer	1.48e-05	0.000557	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	1.48e-05	0.000556	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—STK11—pancreatic cancer	1.46e-05	0.000548	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PIK3CD—pancreatic cancer	1.39e-05	0.000523	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.37e-05	0.000515	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.34e-05	0.000502	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.32e-05	0.000494	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SMAD4—pancreatic cancer	1.3e-05	0.000488	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.29e-05	0.000483	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	1.28e-05	0.00048	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HES1—pancreatic cancer	1.27e-05	0.000476	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.27e-05	0.000475	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HES1—pancreatic cancer	1.25e-05	0.000469	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.22e-05	0.000456	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.2e-05	0.000449	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CXCL8—pancreatic cancer	1.17e-05	0.000438	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	1.15e-05	0.000431	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TERT—pancreatic cancer	1.11e-05	0.000417	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TERT—pancreatic cancer	1.09e-05	0.000411	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HIF1A—pancreatic cancer	1.06e-05	0.000399	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TSC2—pancreatic cancer	1.06e-05	0.000398	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	1.05e-05	0.000393	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	1.04e-05	0.000392	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—APOE—pancreatic cancer	1.04e-05	0.00039	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—APOE—pancreatic cancer	1.02e-05	0.000383	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—KDR—pancreatic cancer	1.02e-05	0.000382	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—KDR—pancreatic cancer	1e-05	0.000376	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NFKBIA—pancreatic cancer	9.68e-06	0.000363	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NOTCH1—pancreatic cancer	9.58e-06	0.00036	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	9.52e-06	0.000357	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	9.43e-06	0.000354	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PIK3CG—pancreatic cancer	9.37e-06	0.000352	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—NRAS—pancreatic cancer	9.37e-06	0.000352	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—EGF—pancreatic cancer	9.26e-06	0.000348	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	9.22e-06	0.000346	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	9.22e-06	0.000346	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—EGF—pancreatic cancer	9.11e-06	0.000342	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—EGFR—pancreatic cancer	8.54e-06	0.00032	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	8.4e-06	0.000315	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PIK3CD—pancreatic cancer	8.24e-06	0.000309	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.16e-06	0.000306	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	8.11e-06	0.000304	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—KRAS—pancreatic cancer	8.07e-06	0.000303	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.03e-06	0.000301	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	7.94e-06	0.000298	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	7.41e-06	0.000278	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	7.29e-06	0.000274	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	7.18e-06	0.000269	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	7.07e-06	0.000265	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	6.9e-06	0.000259	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	6.86e-06	0.000257	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	6.79e-06	0.000255	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	6.75e-06	0.000253	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	6.67e-06	0.00025	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CASP3—pancreatic cancer	6.6e-06	0.000248	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	6.56e-06	0.000246	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	6.5e-06	0.000244	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCND1—pancreatic cancer	6.43e-06	0.000241	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	6.37e-06	0.000239	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	6.33e-06	0.000237	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	6.26e-06	0.000235	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MMP9—pancreatic cancer	6.24e-06	0.000234	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PTEN—pancreatic cancer	6.21e-06	0.000233	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	6.14e-06	0.00023	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	6.11e-06	0.000229	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	6.05e-06	0.000227	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	5.96e-06	0.000224	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SRC—pancreatic cancer	5.75e-06	0.000216	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SRC—pancreatic cancer	5.66e-06	0.000212	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	5.6e-06	0.00021	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—STAT3—pancreatic cancer	5.55e-06	0.000208	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NRAS—pancreatic cancer	5.54e-06	0.000208	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	5.51e-06	0.000207	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	5.46e-06	0.000205	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	5.45e-06	0.000204	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MYC—pancreatic cancer	5.16e-06	0.000194	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	5.14e-06	0.000193	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MYC—pancreatic cancer	5.07e-06	0.00019	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	5.06e-06	0.00019	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—EGFR—pancreatic cancer	5.04e-06	0.000189	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	4.96e-06	0.000186	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—KRAS—pancreatic cancer	4.76e-06	0.000179	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	4.69e-06	0.000176	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	4.38e-06	0.000164	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	4.31e-06	0.000162	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TP53—pancreatic cancer	4.23e-06	0.000159	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TP53—pancreatic cancer	4.17e-06	0.000156	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HRAS—pancreatic cancer	4.05e-06	0.000152	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	3.99e-06	0.00015	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—AKT1—pancreatic cancer	3.58e-06	0.000134	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	3.52e-06	0.000132	CbGpPWpGaD
